ACADIA Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACAD and other ETFs, options, and stocks.About ACAD
ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.
CEOCatherine Owen Adams
CEOCatherine Owen Adams
Employees654
Employees654
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded1993
Founded1993
Employees654
Employees654
ACAD Key Statistics
Market cap3.53B
Market cap3.53B
Price-Earnings ratio15.70
Price-Earnings ratio15.70
Dividend yield—
Dividend yield—
Average volume2.34M
Average volume2.34M
High today$21.34
High today$21.34
Low today$20.54
Low today$20.54
Open price$21.05
Open price$21.05
Volume1.64M
Volume1.64M
52 Week high$26.65
52 Week high$26.65
52 Week low$13.40
52 Week low$13.40
ACAD News
TipRanks 21h
ACADIA Pharmaceuticals: Hold Rating Amid Pipeline Shifts and Product FocusACADIA Pharmaceuticals, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Sean Laaman from Morgan Stanley maintained a Ho...
Simply Wall St 6d
Do ACADIA Pharmaceuticals’ Pipeline Updates Reveal a Shifting Focus Beyond NUPLAZID?Acadia Pharmaceuticals recently presented a late-breaker oral platform presentation and two poster sessions at the International Congress of Parkinson's Disease...
Analyst ratings
63%
of 19 ratingsBuy
63.2%
Hold
31.6%
Sell
5.3%
People also own
Based on the portfolios of people who own ACAD. This list is generated using Robinhood data, and it’s not a recommendation.